albuterol has been researched along with Rhinitis, Allergic, Nonseasonal in 12 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
| Excerpt | Relevance | Reference |
|---|---|---|
| "A post hoc resource use analysis of a 52-week, double-blind multicentre clinical trial (Investigation of Montelukast as a Partner Agent for Complementary Therapy) [corrected] including 1490 adults with chronic asthma, aged 15-72 years, with FEV(1) 50-90% of predicted and > or =12% increase in FEV(1) after salbutamol administration, treated with either montelukast 10 mg daily or salmeterol 50 microg twice daily in addition to fluticasone 200 microg, was undertaken." | 7.73 | Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: a subgroup analysis of the investigation of montelukast as a partner agent for complementary therapy [corrected]. ( Bjermer, L; Bousquet, J; Gaugris, S; Kocevar, VS; Polos, PG; Yin, DD; Zhang, Q, 2005) |
| "A post hoc resource use analysis of a 52-week, double-blind multicentre clinical trial (Investigation of Montelukast as a Partner Agent for Complementary Therapy) [corrected] including 1490 adults with chronic asthma, aged 15-72 years, with FEV(1) 50-90% of predicted and > or =12% increase in FEV(1) after salbutamol administration, treated with either montelukast 10 mg daily or salmeterol 50 microg twice daily in addition to fluticasone 200 microg, was undertaken." | 3.73 | Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: a subgroup analysis of the investigation of montelukast as a partner agent for complementary therapy [corrected]. ( Bjermer, L; Bousquet, J; Gaugris, S; Kocevar, VS; Polos, PG; Yin, DD; Zhang, Q, 2005) |
| " A careful review of his medical history and the mechanisms of drug-induced asthma revealed that the etiology of his death was more likely due to heroin abuse and noncardiogenic pulmonary edema." | 3.69 | The role of pharmacology and forensics in the death of an asthmatic. ( Blaho, K; Merigian, K, 1995) |
| "For the primary outcome there was significant protection after single and long-term dosing with fluticasone alone and fluticasone-salmeterol combination, whereas salmeterol alone only afforded protection after the first dose." | 2.77 | Effects of intranasal salmeterol and fluticasone given alone and in combination in persistent allergic rhinitis. ( Burns, P; Lipworth, BJ; Nair, A; Short, P, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ciprandi, G | 2 |
| Signori, A | 1 |
| Cirillo, I | 1 |
| Lipworth, BJ | 1 |
| Short, P | 1 |
| Burns, P | 1 |
| Nair, A | 1 |
| Chiang, WC | 1 |
| Chen, YM | 1 |
| Tan, HK | 1 |
| Balakrishnan, A | 1 |
| Liew, WK | 1 |
| Lim, HH | 1 |
| Goh, SH | 1 |
| Loh, WY | 1 |
| Wong, P | 1 |
| Teoh, OH | 1 |
| Goh, A | 1 |
| Chay, OM | 1 |
| Tosca, MA | 1 |
| Capasso, M | 1 |
| Brito, FF | 1 |
| Mur, P | 1 |
| Barber, D | 1 |
| Lombardero, M | 1 |
| Galindo, PA | 1 |
| Gómez, E | 1 |
| Borja, J | 1 |
| Marogna, M | 1 |
| Falagiani, P | 1 |
| Bruno, M | 1 |
| Massolo, A | 1 |
| Riva, G | 1 |
| Bousquet, J | 1 |
| Gaugris, S | 1 |
| Kocevar, VS | 1 |
| Zhang, Q | 1 |
| Yin, DD | 1 |
| Polos, PG | 1 |
| Bjermer, L | 1 |
| Kim, K | 1 |
| Quesada, J | 1 |
| Szmaydy-Rikken, N | 1 |
| Darken, P | 1 |
| Shah, T | 1 |
| Pellicer Ciscar, C | 1 |
| Perpiña Tordera, M | 1 |
| de Diego Damia, A | 1 |
| Macián Gisbert, V | 1 |
| Merigian, K | 1 |
| Blaho, K | 1 |
| Boothman-Burrell, D | 1 |
| Jones, D | 1 |
| Herbison, GP | 1 |
| Taylor, DR | 1 |
| Vignale, L | 1 |
| Parentini, GC | 1 |
| Rossi, PC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Proof of Concept Study to Evaluate Effects of Intranasal Salmeterol and Fluticasone Given Alone and in Combination in Allergic Rhinitis[NCT01388595] | Phase 4 | 23 participants (Actual) | Interventional | 2006-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 trials available for albuterol and Rhinitis, Allergic, Nonseasonal
| Article | Year |
|---|---|
Effects of intranasal salmeterol and fluticasone given alone and in combination in persistent allergic rhinitis.
Topics: Adenosine Monophosphate; Administration, Intranasal; Adrenergic beta-2 Receptor Agonists; Adult; Alb | 2012 |
Intranasal ciclesonide coadministration with inhaled fluticasone propionate-salmeterol does not suppress cortisol in allergic rhinitis patients.
Topics: Administration, Inhalation; Administration, Intranasal; Adolescent; Adult; Albuterol; Androstadienes | 2007 |
[Contribution of the bronchodilator test in the study of bronchial reversibility].
Topics: Adult; Albuterol; Asthma; Bronchi; Bronchial Provocation Tests; Bronchitis; Diagnosis, Differential; | 1994 |
The effect of regular salbutamol on lung function and bronchial hyperresponsiveness in normal subjects and nonasthmatic atopic subjects with allergic rhinitis.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Bronchial Hyperreactivity; Bronchia | 1997 |
8 other studies available for albuterol and Rhinitis, Allergic, Nonseasonal
| Article | Year |
|---|---|
Relationship between bronchial hyperreactivity and bronchodilation in patients with allergic rhinitis.
Topics: Adult; Albuterol; Asthma; Bronchi; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchodi | 2011 |
Allergic rhinitis and non-allergic rhinitis in children in the tropics: prevalence and risk associations.
Topics: Adrenal Cortex Hormones; Albuterol; Anti-Allergic Agents; Anti-Asthmatic Agents; Asthma; Child; Chil | 2012 |
High exhaled nitric oxide levels may predict bronchial reversibility in allergic children with asthma or rhinitis.
Topics: Adolescent; Albuterol; Asthma; Breath Tests; Child; Cohort Studies; Cross-Sectional Studies; Female; | 2013 |
Occupational rhinoconjunctivitis and asthma in a wool worker caused by Dermestidae spp.
Topics: Adult; Albuterol; Allergens; Animals; Antibody Specificity; Asthma; Bronchial Provocation Tests; Bro | 2002 |
The allergic march in pollinosis: natural history and therapeutic implications.
Topics: Adolescent; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Child; Coho | 2004 |
Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: a subgroup analysis of the investigation of montelukast as a partner agent for complementary therapy [corrected].
Topics: Acetates; Administration, Inhalation; Adult; Albuterol; Androstadienes; Anti-Allergic Agents; Anti-A | 2005 |
The role of pharmacology and forensics in the death of an asthmatic.
Topics: Administration, Inhalation; Adult; Albuterol; Asthma; Fatal Outcome; Heroin; Humans; Lung; Male; Mor | 1995 |
[Evaluation of the bronchial tonus, basal and following bronchodilators, in subjects with allergic rhinitis].
Topics: Adolescent; Adult; Albuterol; Bronchi; Bronchodilator Agents; Female; Forced Expiratory Volume; Huma | 1989 |